UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 277

Sortiert nach

Factor analytic support for social cognition as a separable cognitive domain in schizophrenia

Schizophrenia research, 2007-07, Vol.93 (1), p.325-333

2007

Link zum Volltext

Verfügbarkeit prüfen

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day

Schizophrenia research, 2012-11, Vol.141 (2), p.144-152

2012

Link zum Volltext

Verfügbarkeit prüfen

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: Comparison with reference dose risperidone, 6mg/day

Schizophrenia research, 2012-11, Vol.141 (2-3), p.144-152

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders

Journal of Huntington's disease, 2018-01, Vol.7 (3), p.355

2018

Link zum Volltext

Verfügbarkeit prüfen

Abnormal age-related changes of plasma antioxidant proteins in schizophrenia

Psychiatry research, 2000-12, Vol.97 (2), p.137-151

2000

Link zum Volltext

Verfügbarkeit prüfen

Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report

The journal of clinical psychiatry, 2002-01, Vol.63 (1), p.15

2002

Link zum Volltext

Verfügbarkeit prüfen

Reduced status of plasma total antioxidant capacity in schizophrenia

Schizophrenia research, 1998-06, Vol.32 (1), p.1-8

1998

Link zum Volltext

Verfügbarkeit prüfen

Empirical Validation of Primary Negative Symptoms: Independence From Effects of Medication and Psychosis

The American journal of psychiatry, 1999-03, Vol.156 (3), p.406-411

1999

Link zum Volltext

Verfügbarkeit prüfen

An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease

PLoS currents, 2011-08, Vol.3, p.RRN1260-RRN1260

2011

Link zum Volltext

Verfügbarkeit prüfen

Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications

CNS drugs, 2001, Vol.15 (4), p.287-310

2001

Link zum Volltext

Verfügbarkeit prüfen

Pimavanserin tartrate, a 5-HT2A receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers

Sleep medicine, 2011-02, Vol.12 (2), p.134-141

2011

Link zum Volltext

Verfügbarkeit prüfen

Human plasma glutathione peroxidase and symptom severity in schizophrenia

Biological psychiatry (1969), 1999-06, Vol.45 (11), p.1512-1515

1999

Link zum Volltext

Verfügbarkeit prüfen

Population admixture modulates risk for alcohol dependence

Human genetics, 2009-06, Vol.125 (5-6), p.605-613

2009

Link zum Volltext

Verfügbarkeit prüfen

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

The American journal of psychiatry, 1995-09, Vol.152 (9), p.1291-1297

1995

Link zum Volltext

Verfügbarkeit prüfen

An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers

Movement disorders, 2011-04, Vol.26 (5), p.877-884

2011

Link zum Volltext

Verfügbarkeit prüfen

Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia

Biological psychiatry (1969), 1998-10, Vol.44 (8), p.667-674

1998

Link zum Volltext

Verfügbarkeit prüfen

An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease

PLoS currents, 2011-08, Vol.3, p.RRN1259-RRN1259

2011

Link zum Volltext

Verfügbarkeit prüfen

An International Survey-based Algorithm for the Pharmacologic Treatment of Obsessive-Compulsive Behaviors in Huntington's Disease

PLoS currents, 2011-09, Vol.3, p.RRN1261-RRN1261

2011

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal progression of negative symptoms in schizophrenia: A new look at an old problem

Schizophrenia research, 2008-10, Vol.105 (1), p.188-196

2008

Link zum Volltext

Verfügbarkeit prüfen

Differential patterns of premorbid academic and social deterioration in patients with schizophrenia

Schizophrenia research, 2005-06, Vol.75 (2), p.389-397

2005

Link zum Volltext

Verfügbarkeit prüfen

Semantic memory in schizophrenia: Association with cell membrane essential fatty acids

Schizophrenia research, 2008-11, Vol.106 (1), p.13-28

2008

Link zum Volltext

Verfügbarkeit prüfen

Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line 'Depressed' Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing Effects

Neuropsychopharmacology, 2003-07, Vol.28 (7), p.1292-1299

2003

Link zum Volltext

Verfügbarkeit prüfen

Automatic activation of the semantic network in schizophrenia: evidence from event-related brain potentials

Biological psychiatry (1969), 2003-12, Vol.54 (11), p.1134-1148

2003

Link zum Volltext

Verfügbarkeit prüfen

Further Studies of Elevated Cerebrospinal Fluid Neuronal Cell Adhesion Molecule in Schizophrenia

Biological psychiatry (1969), 1998-05, Vol.43 (9), p.680-686

1998

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, Tolerability, and Safety of ACP-103 Following Single or Multiple Oral Dose Administration in Healthy Volunteers

Journal of clinical pharmacology, 2007-06, Vol.47 (6), p.704-714

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 277

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(229)

Publikationsform

Artikel
(262)
Reviews
(10)
Buchkapitel
(3)
Bücher
(2)

Sprache

Englisch
(277)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Humans
(177)
Science & Technology
(176)
Life Sciences & Biomedicine
(165)
Psychiatry
(139)
Male
(138)
Adult
(133)
Biological And Medical Sciences
(95)
Medical Sciences
(95)
Schizophrenia
(95)
Psychology. Psychoanalysis. Psychiatry
(88)
Middle Aged
(86)
Schizophrenia - Drug Therapy
(78)
Female
(77)
Schizophrenic Psychology
(75)
Psychopathology. Psychiatry
(66)
Adult And Adolescent Clinical Studies
(53)
Neurosciences & Neurology
(50)
Psychoses
(50)
Psychiatric Status Rating Scales
(44)
Adolescent
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Factor analytic support for social cognition as a separable cognitive domain in schizophrenia

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: Comparison with reference dose risperidone, 6mg/day

Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders

Abnormal age-related changes of plasma antioxidant proteins in schizophrenia

Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report

Reduced status of plasma total antioxidant capacity in schizophrenia

Empirical Validation of Primary Negative Symptoms: Independence From Effects of Medication and Psychosis

An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease

Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications

Pimavanserin tartrate, a 5-HT2A receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers

Human plasma glutathione peroxidase and symptom severity in schizophrenia

Population admixture modulates risk for alcohol dependence

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers

Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia

An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease

An International Survey-based Algorithm for the Pharmacologic Treatment of Obsessive-Compulsive Behaviors in Huntington's Disease

Longitudinal progression of negative symptoms in schizophrenia: A new look at an old problem

Differential patterns of premorbid academic and social deterioration in patients with schizophrenia

Semantic memory in schizophrenia: Association with cell membrane essential fatty acids

Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line 'Depressed' Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing Effects

Automatic activation of the semantic network in schizophrenia: evidence from event-related brain potentials

Further Studies of Elevated Cerebrospinal Fluid Neuronal Cell Adhesion Molecule in Schizophrenia

Pharmacokinetics, Tolerability, and Safety of ACP-103 Following Single or Multiple Oral Dose Administration in Healthy Volunteers

Suchergebnisse filtern